|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Legal settlement expenses | |||||
| Intangible asset impairment | |||||
| Restructuring | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other expenses (income): | |||||
| Interest expense (income), net | |||||
| Loss on early extinguishment of debt | |||||
| Fair value adjustment of contingent consideration | |||||
| Other (income) expense | |||||
| Total other (income) expenses, net | |||||
| Net loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Weighted average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Net loss per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
Loading...